Conventional immunosuppressive therapy in severe Behcet's Uveitis: the switch rate to the biological agents

ÇELİKER ATABERK H., Kazokoglu H., Direskeneli H.

BMC OPHTHALMOLOGY, cilt.18, 2018 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 18
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1186/s12886-018-0929-5
  • Dergi Adı: BMC OPHTHALMOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Anahtar Kelimeler: Anti TNF-alpha therapy, Behcet's uveitis, Immunosuppressive therapy, Interferon therapy, Uveitis, LONG-TERM EFFICACY, INTERFERON ALPHA-2A, DISEASE, SAFETY
  • Marmara Üniversitesi Adresli: Evet

Özet

Background: To report the switch rate of conventional immunosuppressive (CIS) therapies to the biological agents (BA) in patients with refractory Behcet's uveitis (BU).